| Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. | |
| | |
MedLine Citation:
|
PMID: 12743009 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In this study of 10 690 individuals, associations with elevated blood pressure, ischemic heart disease, and ischemic cerebrovascular disease were determined for two noncoding [A(-20)C, G(-6)A] and two coding (T174M, M235T) single nucleotide polymorphisms, analyzed alone and in combination (haplotypes). Participants from the general population with (n=4950) and without (n=4234) elevated blood pressure were compared (study 1), as were participants from the general population without ischemic heart disease and ischemic cerebrovascular disease (n=7965) and cases with either ischemic heart disease (n=1850, study 2) or ischemic cerebrovascular disease (n=848, study 3). Finally, 22-year follow-up of 9184 individuals from the general population examined risk of ischemic heart disease (study 4) and ischemic cerebrovascular disease (study 5). Individuals with -6AA, 174TT, or 235TT had plasma angiotensinogen levels increased by 80 ng/mL (P=0.01 and 0.05 for women and men) compared with individuals with -6GG, 174TT, or 235 MM. In women, this difference was associated with an odds ratio of elevated blood pressure of 1.25 (1.03 to 1.51), which increased to 1.63 (1.05 to 2.51) in postmenopausal women receiving hormone replacement therapy. The promoter single nucleotide polymorphisms alone or as haplotypes did not predict the continuous variables of systolic, diastolic, or pulse pressure in cross section or the risk of ischemic heart disease or ischemic cerebrovascular disease in either gender in case-control or prospective studies. Individuals with -6AA, 174TT, or 235TT in the angiotensinogen gene have increased plasma angiotensinogen levels and moderately increased risk of elevated blood pressure (women only) but unaltered blood pressure examined as a continuous variable and unaltered risk of ischemic heart disease and ischemic cerebrovascular disease. |
| | |
Authors:
|
Amar A Sethi; Børge G Nordestgaard; Marie-Louise M Grønholdt; Rolf Steffensen; Gorm Jensen; Anne Tybjaerg-Hansen |
Related Documents
:
|
9624649 - Influences of cardiorespiratory fitness levels and other predictors on cardiovascular d... 19237679 - Depression is associated with decreased blood pressure, but antidepressant use increase... 12912809 - Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. 6715679 - Preliminary studies in the identification of cardiac status in a cardiac surgical inten... 19508589 - Should we evaluate for cardiovascular disease in patients with cushing's syndrome? 18307439 - Left atrial volume is associated with inflammation and atherosclerosis in patients with... 10572729 - Cerebral doppler sonography of the neonate. a résumé after 20 years and future aspects. 2323509 - Gastroduodenal motility during the delayed gastric emptying induced by cold stress. 18651149 - Use of dynamic ct in acute respiratory distress syndrome (ards) with comparison of posi... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2003-05-12 |
Journal Detail:
|
Title: Hypertension Volume: 41 ISSN: 1524-4563 ISO Abbreviation: Hypertension Publication Date: 2003 Jun |
Date Detail:
|
Created Date: 2003-06-06 Completed Date: 2003-06-27 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7906255 Medline TA: Hypertension Country: United States |
Other Details:
|
Languages: eng Pagination: 1202-11 Citation Subset: IM |
Affiliation:
|
Department of Clinical Biochemistry, Herlev University Hospital, Copenhagen, Denmark. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensinogen
/
genetics* Blood Pressure / genetics* Brain Ischemia / genetics* Case-Control Studies Female Gene Frequency Genetic Predisposition to Disease Genotype Haplotypes Humans Male Middle Aged Myocardial Ischemia / genetics* Polymorphism, Single Nucleotide* Prospective Studies |
| Chemical | |
Reg. No./Substance:
|
11002-13-4/Angiotensinogen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.
Next Document: Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells v...